Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Santarus commences SAN-300 Phase I clinical study to treat inflammatory diseases

Santarus commences SAN-300 Phase I clinical study to treat inflammatory diseases

10 Mar 2011
ALR commits funding for new study to identify lupus susceptibility genes in multiple ethnicities

ALR commits funding for new study to identify lupus susceptibility genes in multiple ethnicities

10 Mar 2011
Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

9 Mar 2011
Karolinska Institutet, LUMC coordinate largest European program on RA

Karolinska Institutet, LUMC coordinate largest European program on RA

9 Mar 2011
Recent rituximab trial with TNF inhibitors reports no new safety risks in patients with RA

Recent rituximab trial with TNF inhibitors reports no new safety risks in patients with RA

8 Mar 2011
Arthritis handle kitchen tool for RA sufferers

Arthritis handle kitchen tool for RA sufferers

8 Mar 2011
North Shore-LIJ launches new prenatal quality initiative

North Shore-LIJ launches new prenatal quality initiative

8 Mar 2011
Dr Russell Wallis, Reader and RCUK Academic Fellow to give Frank May Prize Lecture 2010

Dr Russell Wallis, Reader and RCUK Academic Fellow to give Frank May Prize Lecture 2010

5 Mar 2011
Pfizer's ORAL Sync Phase 3 study of tofacitinib in moderate-to-severe RA meets primary endpoints

Pfizer's ORAL Sync Phase 3 study of tofacitinib in moderate-to-severe RA meets primary endpoints

5 Mar 2011
Triptolide isolated from Chinese medicinal plant blocks gene control machinery in cells

Triptolide isolated from Chinese medicinal plant blocks gene control machinery in cells

4 Mar 2011
Protalex initiates enrollment in 3rd cohort of PRTX-100 Phase 1b dose escalation clinical study in RA

Protalex initiates enrollment in 3rd cohort of PRTX-100 Phase 1b dose escalation clinical study in RA

3 Mar 2011
Early diagnosis of juvenile idiopathic arthritis critical to avoid disability, deformity

Early diagnosis of juvenile idiopathic arthritis critical to avoid disability, deformity

3 Mar 2011
New PSA campaign to raise awareness about autoimmune diseases

New PSA campaign to raise awareness about autoimmune diseases

2 Mar 2011
Daiichi Sankyo enters merger agreement to acquire Plexxikon

Daiichi Sankyo enters merger agreement to acquire Plexxikon

28 Feb 2011
Regeneron's ARCALYST meets primary, secondary endpoints in second Phase 3 gout flare study

Regeneron's ARCALYST meets primary, secondary endpoints in second Phase 3 gout flare study

28 Feb 2011
SQI Diagnostics first quarter net loss increases to $2,255,000

SQI Diagnostics first quarter net loss increases to $2,255,000

28 Feb 2011
Final data from 4SC vidofludimus ENTRANCE Phase IIa trial against IBD presented at ECCO IBD Conference

Final data from 4SC vidofludimus ENTRANCE Phase IIa trial against IBD presented at ECCO IBD Conference

28 Feb 2011
Pharming, Santarus receive FDA refusal to file letter for RHUCIN BLA

Pharming, Santarus receive FDA refusal to file letter for RHUCIN BLA

28 Feb 2011
Protalix receives FDA CRL for taliglucerase alfa NDA for Gaucher disease

Protalix receives FDA CRL for taliglucerase alfa NDA for Gaucher disease

25 Feb 2011
Research sheds new light on problem of insulin resistance in type 2 diabetes

Research sheds new light on problem of insulin resistance in type 2 diabetes

25 Feb 2011

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback